Philadelphia and London, (ANTARA News/PRNewswire-AsiaNet) - The Scientific business of Thomson Reuters today announced the early findings of its 2008 Liquent Regulatory Affairs Trends Survey.
The survey attracted respondents from across the globe representing small, medium and large pharmaceutical companies and provides a unique insight into emerging and future trends in regulatory product management usage and
adoption.
Now in its sixth year and frequently sourced by pharmaceutical journals and publications across the world, this survey has become the premier benchmark of global regulatory submission trends offering timely insights into how pharmaceutical regulatory professionals use technology today and how they plan to harness technology in the future.
There were 137 Regulatory Affairs professionals working in Life Sciences companies across the globe who participated in this survey. The survey concentrates on four key areas: Technology Usage Trends, including both submission publishing software and other desktop software, Document Management System usage, Regulatory Outsourcing trends, and Regulatory trends including use or future use of the electronic Common Technical Document (eCTD).
The demographic make-up of the respondent population is similar to previous years with almost one third working in large pharmaceutical companies (32 per cent) and more than a third working in small to medium companies (36 per cent).
Another 10 per cent of respondents work for biotechnology companies. There were significantly more respondents from Contract Research Organizations (CROs) in 2008 (10 per cent) than in 2007 (4 per cent). 68 per cent of those surveyed are from the United States and the majority of the remaining respondents are from Europe, with France (4 per cent), Switzerland (4 per cent), the UK (3 per cent) and Germany (3 per cent) the most highly represented.
Survey highlights include:
Technology Usage:
-- Almost all (92 per cent) of the survey respondents make regulatory submissions, a slight increase on 2007 (90 per cent); current use of paper and electronic submissions has remained the same since 2007.
-- Three-quarters (75 per cent) are using submission publishing software, similar to 2007 (67 per cent). Approximately one-third (31 per cent) of those respondents not currently using software are very likely to implement submission publishing software into their process.
-- As in 2007, the SAFE initiative has not yet taken hold in most companies surveyed: only 2 per cent of respondents are currently addressing it.
However, there has been a significant increase in the percentage of companies that are currently using technology to support the FDA Gateway, up to 19 per cent this year, from 9 per cent in 2007.
Regulatory Outsourcing Trends:
-- 30 per cent of respondents do not outsource any of their regulatory operations.
-- Printing (28 per cent) was the regulatory operation outsourced the most by respondents.
Regulatory Trends:
-- Eight in ten (83 per cent) of respondents intend to migrate to the eCTD, with 20 per cent of these reporting they will migrate within the next year.
"This year's survey has once again attracted respondents from across the breadth of the global life sciences industry, with large as well as small to medium sized companies participating," said Jim Nichols, Liquent's Vice President of Product Strategy and Marketing, who launched this worldwide initiative in 2003. "We're particularly excited to see a significant increase in the numbers of Contract Research Organizations (CROs) replying to our survey, further diversifying the population sample."
Full results of the survey are available on request at the following address: http://www.liquent.com/2008survey/
For more information about Liquent regulatory information management services, please go to: http:/www.thomsonreuters.com/products_services/scientific1 liquentinsight
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.
SOURCE Thomson Reuters
CONTACT: Eoin Bedford of Thomson Reuters, Scientific,
+44-207-433-4691, eoin.bedford@thomsonreuters.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20080424NYTH069LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.thomsonreuters.com
http://www.liquent.com/2008survey
http://www.thomsonreuters.com/products_services/scientific1
liquentinsight
The survey attracted respondents from across the globe representing small, medium and large pharmaceutical companies and provides a unique insight into emerging and future trends in regulatory product management usage and
adoption.
Now in its sixth year and frequently sourced by pharmaceutical journals and publications across the world, this survey has become the premier benchmark of global regulatory submission trends offering timely insights into how pharmaceutical regulatory professionals use technology today and how they plan to harness technology in the future.
There were 137 Regulatory Affairs professionals working in Life Sciences companies across the globe who participated in this survey. The survey concentrates on four key areas: Technology Usage Trends, including both submission publishing software and other desktop software, Document Management System usage, Regulatory Outsourcing trends, and Regulatory trends including use or future use of the electronic Common Technical Document (eCTD).
The demographic make-up of the respondent population is similar to previous years with almost one third working in large pharmaceutical companies (32 per cent) and more than a third working in small to medium companies (36 per cent).
Another 10 per cent of respondents work for biotechnology companies. There were significantly more respondents from Contract Research Organizations (CROs) in 2008 (10 per cent) than in 2007 (4 per cent). 68 per cent of those surveyed are from the United States and the majority of the remaining respondents are from Europe, with France (4 per cent), Switzerland (4 per cent), the UK (3 per cent) and Germany (3 per cent) the most highly represented.
Survey highlights include:
Technology Usage:
-- Almost all (92 per cent) of the survey respondents make regulatory submissions, a slight increase on 2007 (90 per cent); current use of paper and electronic submissions has remained the same since 2007.
-- Three-quarters (75 per cent) are using submission publishing software, similar to 2007 (67 per cent). Approximately one-third (31 per cent) of those respondents not currently using software are very likely to implement submission publishing software into their process.
-- As in 2007, the SAFE initiative has not yet taken hold in most companies surveyed: only 2 per cent of respondents are currently addressing it.
However, there has been a significant increase in the percentage of companies that are currently using technology to support the FDA Gateway, up to 19 per cent this year, from 9 per cent in 2007.
Regulatory Outsourcing Trends:
-- 30 per cent of respondents do not outsource any of their regulatory operations.
-- Printing (28 per cent) was the regulatory operation outsourced the most by respondents.
Regulatory Trends:
-- Eight in ten (83 per cent) of respondents intend to migrate to the eCTD, with 20 per cent of these reporting they will migrate within the next year.
"This year's survey has once again attracted respondents from across the breadth of the global life sciences industry, with large as well as small to medium sized companies participating," said Jim Nichols, Liquent's Vice President of Product Strategy and Marketing, who launched this worldwide initiative in 2003. "We're particularly excited to see a significant increase in the numbers of Contract Research Organizations (CROs) replying to our survey, further diversifying the population sample."
Full results of the survey are available on request at the following address: http://www.liquent.com/2008survey/
For more information about Liquent regulatory information management services, please go to: http:/www.thomsonreuters.com/products_services/scientific1 liquentinsight
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.
SOURCE Thomson Reuters
CONTACT: Eoin Bedford of Thomson Reuters, Scientific,
+44-207-433-4691, eoin.bedford@thomsonreuters.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20080424NYTH069LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.thomsonreuters.com
http://www.liquent.com/2008survey
http://www.thomsonreuters.com/products_services/scientific1
liquentinsight
